DAPK1 and plasma cell myeloma: Safingol synergistically sensitized epigallocatechin-induced apoptotic cell death, and suppressed multiple myeloma cells by preventing protein tyrosine kinase phoshorylation and activation of death-associated protein kinase 1 (DAPK1) [151].